{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:37:04Z","timestamp":1787621824634,"version":"build-2736575974"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172230"],"award-info":[{"award-number":["82172230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Changchun Scientific and Technological Development Program","award":["21ZGY29"],"award-info":[{"award-number":["21ZGY29"]}]},{"name":"Life Spring AKY Pharmaceuticals","award":["3R218FM83430"],"award-info":[{"award-number":["3R218FM83430"]}]},{"name":"the Jilin Scientific and Technological Development Program","award":["20240205001YY"],"award-info":[{"award-number":["20240205001YY"]}]},{"name":"the Jilin Health Service Capacity Improvement Program","award":["2017F014"],"award-info":[{"award-number":["2017F014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06187-w","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T14:06:50Z","timestamp":1748700410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Microbiome in prostate cancer: pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies"],"prefix":"10.1007","volume":"151","author":[{"given":"Chengran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin\u2019ao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuce","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"6187_CR1","doi-asserted-by":"publisher","first-page":"EBO.S36436","DOI":"10.4137\/EBO.S36436","volume":"12s1","author":"V Aguiar-Pulido","year":"2016","unstructured":"Aguiar-Pulido V, Huang W, Suarez-Ulloa V, Cickovski T, Mathee K, Narasimhan G (2016) Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis: supplementary issue: bioinformatics methods and applications for big metagenomics data. Evol Bioinform Online 12s1:EBO.S36436","journal-title":"Evol Bioinform Online"},{"issue":"1","key":"6187_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/pros.23713","volume":"79","author":"S Alanee","year":"2019","unstructured":"Alanee S, El-Zawahry A, Dynda D, Dabaja A, McVary K, Karr M et al (2019) A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis. Prostate 79(1):81\u201387","journal-title":"Prostate"},{"issue":"6","key":"6187_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14(6):356\u2013365","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"6187_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000365705","volume":"8","author":"MS Al-Marhoon","year":"2015","unstructured":"Al-Marhoon MS, Ouhtit A, Al-Abri AO, Venkiteswaran KP, Al-Busaidi Q, Mathew J et al (2015) Molecular evidence of helicobacter pylori infection in prostate tumors. Curr Urol 8(3):138\u2013143","journal-title":"Curr Urol"},{"issue":"1","key":"6187_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41467-018-03900-x","volume":"9","author":"JF Anker","year":"2018","unstructured":"Anker JF, Naseem AF, Mok H, Schaeffer AJ, Abdulkadir SA, Thumbikat P (2018) Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun 9(1):1591","journal-title":"Nat Commun"},{"key":"6187_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cca.2019.12.010","volume":"503","author":"H Antushevich","year":"2020","unstructured":"Antushevich H (2020) Fecal microbiota transplantation in disease therapy. Clin Chim Acta 503:90\u201398","journal-title":"Clin Chim Acta"},{"issue":"6","key":"6187_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/carcin\/bgz008","volume":"40","author":"S Banerjee","year":"2019","unstructured":"Banerjee S, Alwine JC, Wei Z, Tian T, Shih N, Sperling C et al (2019) Microbiome signatures in prostate cancer. Carcinogenesis 40(6):749\u2013764","journal-title":"Carcinogenesis"},{"issue":"1","key":"6187_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jvim.14875","volume":"32","author":"PC Barko","year":"2018","unstructured":"Barko PC, McMichael MA, Swanson KS, Williams DA (2018) The gastrointestinal microbiome: a review. Vet Internal Med 32(1):9\u201325","journal-title":"Vet Internal Med"},{"issue":"3","key":"6187_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41579-021-00621-9","volume":"20","author":"A Bauermeister","year":"2022","unstructured":"Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, Jarmusch AK, Dorrestein PC (2022) Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol 20(3):143\u2013160","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"6187_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mcna.2017.11.001","volume":"102","author":"WJ Catalona","year":"2018","unstructured":"Catalona WJ (2018) Prostate cancer screening. Med Clin North Am 102(2):199\u2013214","journal-title":"Med Clin North Am"},{"issue":"4","key":"6187_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.eururo.2017.03.029","volume":"72","author":"I Cavarretta","year":"2017","unstructured":"Cavarretta I, Ferrarese R, Cazzaniga W, Saita D, Lucian\u00f2 R, Ceresola ER et al (2017) The microbiome of the prostate tumor microenvironment. Eur Urol 72(4):625\u2013631","journal-title":"Eur Urol"},{"issue":"3","key":"6187_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00203-021-02200-1","volume":"203","author":"HU Celebioglu","year":"2021","unstructured":"Celebioglu HU (2021) Effects of potential synbiotic interaction between Lactobacillus rhamnosus GG and salicylic acid on human colon and prostate cancer cells. Arch Microbiol 203(3):1221\u20131229","journal-title":"Arch Microbiol"},{"issue":"11","key":"6187_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.805459","volume":"10","author":"B Che","year":"2021","unstructured":"Che B, Zhang W, Xu S, Yin J, He J, Huang T et al (2021) Prostate microbiota and prostate cancer: a new trend in treatment. Front Oncol 10(11):805459","journal-title":"Front Oncol"},{"issue":"1","key":"6187_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N et al (2021) Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol 23(1):87\u201398","journal-title":"Nat Cell Biol"},{"issue":"13","key":"6187_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.935846","volume":"15","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wu FH, Wu PQ, Xing HY, Ma T (2022) The role of the tumor microbiome in tumor development and its treatment. Front Immunol 15(13):935846","journal-title":"Front Immunol"},{"issue":"10","key":"6187_CR16","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","volume":"69","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu CY, Yu J (2020) The role of gut microbiota in cancer treatment: friend or foe? Gut 69(10):1867\u20131876","journal-title":"Gut"},{"issue":"4","key":"6187_CR17","doi-asserted-by":"publisher","first-page":"e00053","DOI":"10.1128\/CMR.00053-19","volume":"33","author":"DL Church","year":"2020","unstructured":"Church DL, Cerutti L, G\u00fcrtler A, Griener T, Zelazny A, Emler S (2020) Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev 33(4):e00053-e119","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"6187_CR18","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1097\/01.ju.0000158161.15277.78","volume":"173","author":"RJ Cohen","year":"2005","unstructured":"Cohen RJ, Shannon BA, McNEAL JE, Shannon T, Garrett KL (2005) Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 173(6):1969\u20131974","journal-title":"J Urol"},{"issue":"5960","key":"6187_CR19","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.1177486","volume":"326","author":"EK Costello","year":"2009","unstructured":"Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R (2009) Bacterial community variation in human body habitats across space and time. Science 326(5960):1694\u20131697","journal-title":"Science"},{"issue":"9","key":"6187_CR20","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.3390\/nu12092648","volume":"12","author":"F Crocetto","year":"2020","unstructured":"Crocetto F, Boccellino M, Barone B, Di Zazzo E, Sciarra A, Galasso G et al (2020) The crosstalk between prostate cancer and microbiota inflammation: nutraceutical products are useful to balance this interplay? Nutrients 12(9):2648","journal-title":"Nutrients"},{"key":"6187_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molmet.2018.05.016","volume":"15","author":"TWL Cross","year":"2018","unstructured":"Cross TWL, Kasahara K, Rey FE (2018) Sexual dimorphism of cardiometabolic dysfunction: gut microbiome in the play? Mol Metab 15:70\u201381","journal-title":"Mol Metab"},{"issue":"5","key":"6187_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12038-019-9926-y","volume":"44","author":"B Das","year":"2019","unstructured":"Das B, Nair GB (2019) Homeostasis and dysbiosis of the gut microbiome in health and disease. J Biosci 44(5):117","journal-title":"J Biosci"},{"issue":"1","key":"6187_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12915-017-0454-7","volume":"15","author":"ER Davenport","year":"2017","unstructured":"Davenport ER, Sanders JG, Song SJ, Amato KR, Clark AG, Knight R (2017) The human microbiome in evolution. BMC Biol 15(1):127","journal-title":"BMC Biol"},{"issue":"8","key":"6187_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","volume":"20","author":"JS De Bono","year":"2020","unstructured":"De Bono JS, Guo C, Gurel B, De Marzo AM, Sfanos KS, Mani RS et al (2020) Prostate carcinogenesis: inflammatory storms. Nat Rev Cancer 20(8):455\u2013469","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"6187_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jcb.10747","volume":"91","author":"AM De Marzo","year":"2004","unstructured":"De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI et al (2004) Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 91(3):459\u2013477","journal-title":"J Cell Biochem"},{"issue":"2","key":"6187_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/mc.21948","volume":"53","author":"B Debelec-Butuner","year":"2014","unstructured":"Debelec-Butuner B, Alapinar C, Varisli L, Erbaykent-Tepedelen B, Hamid SM, Gonen-Korkmaz C et al (2014) Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation. Mol Carcinogen 53(2):85\u201397","journal-title":"Mol Carcinogen"},{"issue":"10","key":"6187_CR27","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1128\/AEM.68.10.5186-5190.2002","volume":"68","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ (2002) Acetate utilization and butyryl coenzyme A (CoA): acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 68(10):5186\u20135190","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"6187_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pros.20445","volume":"67","author":"JE Elkahwaji","year":"2007","unstructured":"Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W (2007) Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 67(1):14\u201321","journal-title":"Prostate"},{"issue":"49","key":"6187_CR29","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1074\/jbc.RA119.010950","volume":"294","author":"SM Ervin","year":"2019","unstructured":"Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S et al (2019) Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem 294(49):18586\u201318599","journal-title":"J Biol Chem"},{"issue":"6","key":"6187_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/jnci\/djp019","volume":"101","author":"JC Figueiredo","year":"2009","unstructured":"Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS et al (2009) Folic acid and risk of prostate cancer: results from a randomized clinical trial. JNCI J Natl Cancer Inst 101(6):432\u2013435","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"5","key":"6187_CR31","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/cancers15051375","volume":"15","author":"K Fujita","year":"2023","unstructured":"Fujita K, Matsushita M, De Velasco MA, Hatano K, Minami T, Nonomura N et al (2023) The gut-prostate axis: a new perspective of prostate cancer biology through the gut microbiome. Cancers 15(5):1375","journal-title":"Cancers"},{"issue":"3","key":"6187_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10620-020-06091-y","volume":"65","author":"J Galloway-Pe\u00f1a","year":"2020","unstructured":"Galloway-Pe\u00f1a J, Hanson B (2020) Tools for analysis of the microbiome. Dig Dis Sci 65(3):674\u2013685","journal-title":"Dig Dis Sci"},{"issue":"5778","key":"6187_CR33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355\u20131359","journal-title":"Science"},{"issue":"1","key":"6187_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1186\/s12885-022-09521-4","volume":"22","author":"P Gnagnarella","year":"2022","unstructured":"Gnagnarella P, Marvaso G, Jereczek-Fossa BA, De Cobelli O, Simoncini MC, Nevola Teixeira LF et al (2022) Life style and interaction with microbiota in prostate cancer patients undergoing radiotherapy: study protocol for a randomized controlled trial. BMC Cancer 22(1):794","journal-title":"BMC Cancer"},{"key":"6187_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","volume":"111","author":"DM Golombos","year":"2018","unstructured":"Golombos DM, Ayangbesan A, O\u2019Malley P, Lewicki P, Barlow L, Barbieri CE et al (2018) The role of gut microbiome in the pathogenesis of prostate cancer: a prospective pilot study. Urology 111:122\u2013128","journal-title":"Urology"},{"issue":"6371","key":"6187_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103","journal-title":"Science"},{"issue":"5","key":"6187_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/path.5236","volume":"247","author":"T Hamada","year":"2019","unstructured":"Hamada T, Nowak JA, Milner DA, Song M, Ogino S (2019) Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol 247(5):615\u2013628","journal-title":"J Pathol"},{"issue":"10","key":"6187_CR38","doi-asserted-by":"publisher","first-page":"R245","DOI":"10.1016\/S1074-5521(98)90108-9","volume":"5","author":"J Handelsman","year":"1998","unstructured":"Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM (1998) Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol 5(10):R245\u2013R249","journal-title":"Chem Biol"},{"issue":"6","key":"6187_CR39","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e40","volume":"24","author":"Z Harmak","year":"2024","unstructured":"Harmak Z, Kone AS, Ghouzlani A, Ghazi B, Badou A (2024) Beyond tumor borders: intratumoral microbiome effects on tumor behavior and therapeutic responses. Immune Netw 24(6):e40","journal-title":"Immune Netw"},{"issue":"1","key":"6187_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/iju.13243","volume":"24","author":"JD Henning","year":"2017","unstructured":"Henning JD, Bonachea LA, Bunker CH, Patrick AL, Jenkins FJ (2017) Human herpesvirus 8 infection contributes to a T helper 2 immune response in men from Tobago with prostate cancer. Int J Urol 24(1):64\u201368","journal-title":"Int J Urol"},{"key":"6187_CR41","doi-asserted-by":"publisher","unstructured":"Hullar MAJ, Burnett-Hartman AN, Lampe JW. Gut Microbes, Diet, and Cancer. In: Zappia V, Panico S, Russo GL, Budillon A, Della Ragione F, editors. Advances in Nutrition and Cancer [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014 [cited 2024 Mar 26]. p. 377\u201399. (Cancer Treatment and Research; vol. 159). https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-3-642-38007-5_22","DOI":"10.1007\/978-3-642-38007-5_22"},{"issue":"1","key":"6187_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2015.12.018","volume":"372","author":"JE Hwang","year":"2016","unstructured":"Hwang JE, Joung JY, Shin SP, Choi MK, Kim JE, Kim YH et al (2016) Ad5\/35E1aPSESE4: a novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA\/PSMA transcription regulatory elements. Cancer Lett 372(1):57\u201364","journal-title":"Cancer Lett"},{"issue":"6161","key":"6187_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342(6161):967\u2013970","journal-title":"Science"},{"issue":"1","key":"6187_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13027-020-00319-2","volume":"15","author":"P Katongole","year":"2020","unstructured":"Katongole P, Sande OJ, Joloba M, Reynolds SJ, Niyonzima N (2020) The human microbiome and its link in prostate cancer risk and pathogenesis. Infect Agents Cancer 15(1):53","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"6187_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2014.290","volume":"135","author":"M Kistowska","year":"2015","unstructured":"Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T et al (2015) Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients. J Invest Dermatol 135(1):110\u2013118","journal-title":"J Invest Dermatol"},{"issue":"2","key":"6187_CR46","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/ijms24021511","volume":"24","author":"N Kustrimovic","year":"2023","unstructured":"Kustrimovic N, Bombelli R, Baci D, Mortara L (2023) Microbiome and prostate cancer: a novel target for prevention and treatment. IJMS. 24(2):1511","journal-title":"IJMS."},{"issue":"1","key":"6187_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13027-022-00427-1","volume":"17","author":"JS Lawson","year":"2022","unstructured":"Lawson JS, Glenn WK (2022) Multiple pathogens and prostate cancer. Infect Agents Cancer 17(1):23","journal-title":"Infect Agents Cancer"},{"issue":"5","key":"6187_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","volume":"74","author":"MA Liss","year":"2018","unstructured":"Liss MA, White JR, Goros M, Gelfond J, Leach R, Johnson-Pais T et al (2018) Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer. Eur Urol 74(5):575\u2013582","journal-title":"Eur Urol"},{"issue":"5","key":"6187_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13238-020-00724-8","volume":"12","author":"YX Liu","year":"2021","unstructured":"Liu YX, Qin Y, Chen T, Lu M, Qian X, Guo X et al (2021) A practical guide to amplicon and metagenomic analysis of microbiome data. Protein Cell 12(5):315\u2013330","journal-title":"Protein Cell"},{"issue":"10","key":"6187_CR50","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fmicb.2019.01664","volume":"19","author":"X Ma","year":"2019","unstructured":"Ma X, Chi C, Fan L, Dong B, Shao X, Xie S et al (2019) The microbiome of prostate fluid is associated with prostate cancer. Front Microbiol 19(10):1664","journal-title":"Front Microbiol"},{"issue":"9","key":"6187_CR51","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3390\/cancers12092524","volume":"12","author":"J Ma","year":"2020","unstructured":"Ma J, Gnanasekar A, Lee A, Li WT, Haas M, Wang-Rodriguez J et al (2020) Influence of intratumor microbiome on clinical outcome and immune processes in prostate cancer. Cancers 12(9):2524","journal-title":"Cancers"},{"issue":"4","key":"6187_CR52","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.eururo.2018.12.043","volume":"75","author":"MC Markowski","year":"2019","unstructured":"Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Maleki Vareki S et al (2019) The microbiome and genitourinary cancer: a collaborative review. Eur Urol 75(4):637\u2013646","journal-title":"Eur Urol"},{"issue":"4","key":"6187_CR53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/cancers11040459","volume":"11","author":"F Massari","year":"2019","unstructured":"Massari F, Mollica V, Di Nunno V, Gatto L, Santoni M, Scarpelli M et al (2019) The human microbiota and prostate cancer: friend or foe? Cancers 11(4):459","journal-title":"Cancers"},{"issue":"2","key":"6187_CR54","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","volume":"160","author":"V Matson","year":"2021","unstructured":"Matson V, Chervin CS, Gajewski TF (2021) Cancer and the microbiome\u2014influence of the commensal microbiota on cancer, immune responses, and immunotherapy. Gastroenterology 160(2):600\u2013613","journal-title":"Gastroenterology"},{"issue":"8","key":"6187_CR55","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1111\/cas.14998","volume":"112","author":"M Matsushita","year":"2021","unstructured":"Matsushita M, Fujita K, Motooka D, Hatano K, Fukae S, Kawamura N et al (2021) The gut microbiota associated with high-Gleason prostate cancer. Cancer Sci 112(8):3125\u20133135","journal-title":"Cancer Sci"},{"issue":"3","key":"6187_CR56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.5534\/wjmh.210190","volume":"40","author":"M Matsushita","year":"2022","unstructured":"Matsushita M, Fujita K, Motooka D, Hatano K, Hata J, Nishimoto M et al (2022) Firmicutes in gut microbiota correlate with blood testosterone levels in elderly men. World J Mens Health 40(3):517","journal-title":"World J Mens Health"},{"key":"6187_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.trsl.2018.11.004","volume":"206","author":"MJ McAllister","year":"2019","unstructured":"McAllister MJ, Underwood MA, Leung HY, Edwards J (2019) A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer. Transl Res 206:91\u2013106","journal-title":"Transl Res"},{"issue":"3","key":"6187_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ctim.2015.03.008","volume":"23","author":"M Mego","year":"2015","unstructured":"Mego M, Chovanec J, Vochyanova-Andrezalova I, Konkolovsky P, Mikulova M, Reckova M et al (2015) Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complement Ther Med 23(3):356\u2013362","journal-title":"Complement Ther Med"},{"issue":"4","key":"6187_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13409","volume":"23","author":"N Michels","year":"2022","unstructured":"Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I (2022) Human microbiome and metabolic health: an overview of systematic reviews. Obes Rev 23(4):e13409","journal-title":"Obes Rev"},{"issue":"1","key":"6187_CR60","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1186\/s12885-023-11383-3","volume":"23","author":"W Mingdong","year":"2023","unstructured":"Mingdong W, Xiang G, Yongjun Q, Mingshuai W, Hao P (2023) Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study. BMC Cancer 23(1):854","journal-title":"BMC Cancer"},{"issue":"1","key":"6187_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cncr.33893","volume":"128","author":"G Mjaess","year":"2022","unstructured":"Mjaess G, Karam A, Aoun F, Albisinni S, Roumegu\u00e8re T (2022) Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature. Cancer 128(1):14\u201319","journal-title":"Cancer"},{"issue":"9","key":"6187_CR62","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3390\/cancers15092539","volume":"15","author":"R Munteanu","year":"2023","unstructured":"Munteanu R, Feder RI, Onaciu A, Munteanu VC, Iuga CA, Gulei D (2023) Insights into the human microbiome and its connections with prostate cancer. Cancers 15(9):2539","journal-title":"Cancers"},{"issue":"3","key":"6187_CR63","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1586\/eem.11.20","volume":"6","author":"JL Nelles","year":"2011","unstructured":"Nelles JL, Hu WY, Prins GS (2011) Estrogen action and prostate cancer. Expert Rev Endocrinol Metab 6(3):437\u2013451","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"6187_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11684-019-0731-7","volume":"15","author":"S Ohadian Moghadam","year":"2021","unstructured":"Ohadian Moghadam S, Momeni SA (2021) Human microbiome and prostate cancer development: current insights into the prevention and treatment. Front Med 15(1):11\u201332","journal-title":"Front Med"},{"issue":"3","key":"6187_CR65","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/ijms22031446","volume":"22","author":"M Oliva","year":"2021","unstructured":"Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B et al (2021) Tumor-associated microbiome: where do we stand? IJMS 22(3):1446","journal-title":"IJMS"},{"key":"6187_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100822","volume":"32","author":"LB Peiffer","year":"2022","unstructured":"Peiffer LB, White JR, Jones CB, Slottke RE, Ernst SE, Moran AE et al (2022) Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab). Neoplasia 32:100822","journal-title":"Neoplasia"},{"issue":"6564","key":"6187_CR67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","volume":"374","author":"N Pernigoni","year":"2021","unstructured":"Pernigoni N, Zagato E, Calcinotto A, Troiani M, Mestre RP, Cal\u00ec B et al (2021) Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science 374(6564):216\u2013224","journal-title":"Science"},{"key":"6187_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2019.06.004","volume":"141","author":"SL Picardo","year":"2019","unstructured":"Picardo SL, Coburn B, Hansen AR (2019) The microbiome and cancer for clinicians. Crit Rev Oncol\/hematol 141:1\u201312","journal-title":"Crit Rev Oncol\/hematol"},{"issue":"10","key":"6187_CR69","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1158\/1055-9965.EPI-17-0503","volume":"26","author":"EA Platz","year":"2017","unstructured":"Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG et al (2017) A prospective study of chronic inflammation in benign prostate tissue and risk of prostate cancer: linked PCPT and SELECT cohorts. Cancer Epidemiol Biomarkers Prevent 26(10):1549\u20131557","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"issue":"4","key":"6187_CR70","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324\u2013335","journal-title":"Cell Host Microbe"},{"issue":"3","key":"6187_CR71","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41391-018-0041-1","volume":"21","author":"CM Porter","year":"2018","unstructured":"Porter CM, Shrestha E, Peiffer LB, Sfanos KS (2018) The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis 21(3):345\u2013354","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"6187_CR72","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.euf.2016.08.010","volume":"2","author":"M Puhr","year":"2016","unstructured":"Puhr M, De Marzo A, Isaacs W, Lucia MS, Sfanos K, Yegnasubramanian S et al (2016) Inflammation, microbiota, and prostate cancer. Eur Urol Focus 2(4):374\u2013382","journal-title":"Eur Urol Focus"},{"issue":"4","key":"6187_CR73","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1158\/1940-6207.CAPR-16-0249","volume":"10","author":"SV Rajagopala","year":"2017","unstructured":"Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A et al (2017) The human microbiome and cancer. Cancer Prevent Res 10(4):226\u2013234","journal-title":"Cancer Prevent Res"},{"issue":"3","key":"6187_CR74","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/v13030449","volume":"13","author":"SD Rezaei","year":"2021","unstructured":"Rezaei SD, Hayward JA, Norden S, Pedersen J, Mills J, Hearps AC et al (2021) HERV-K Gag RNA and protein levels are elevated in malignant regions of the prostate in males with prostate cancer. Viruses 13(3):449","journal-title":"Viruses"},{"key":"6187_CR75","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.semcancer.2021.09.007","volume":"86","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F (2022) Microbiota and prostate cancer. Semin Cancer Biol 86:1058\u20131065","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"6187_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13073-022-01011-3","volume":"14","author":"PV Salachan","year":"2022","unstructured":"Salachan PV, Rasmussen M, Freds\u00f8e J, Ulh\u00f8i B, Borre M, S\u00f8rensen KD (2022) Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling. Genome Med 14(1):9","journal-title":"Genome Med"},{"issue":"7","key":"6187_CR77","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/biology12070997","volume":"12","author":"H Satam","year":"2023","unstructured":"Satam H, Joshi K, Mangrolia U, Waghoo S, Zaidi G, Rawool S et al (2023) Next-generation sequencing technology: current trends and advancements. Biology 12(7):997","journal-title":"Biology"},{"issue":"11","key":"6187_CR78","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13(11):800\u2013812","journal-title":"Nat Rev Cancer"},{"issue":"6536","key":"6187_CR79","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R (2021) The microbiome and human cancer. Science 371(6536):4552","journal-title":"Science"},{"issue":"3","key":"6187_CR80","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/pros.20680","volume":"68","author":"KS Sfanos","year":"2008","unstructured":"Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68(3):306\u2013320","journal-title":"Prostate"},{"issue":"1","key":"6187_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM (2018) The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol 15(1):11\u201324","journal-title":"Nat Rev Urol"},{"issue":"Suppl 1","key":"6187_CR82","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.4111\/icu.2020.61.S1.S43","volume":"61","author":"S Sha","year":"2020","unstructured":"Sha S, Ni L, Stefil M, Dixon M, Mouraviev V (2020) The human gastrointestinal microbiota and prostate cancer development and treatment. Investig Clin Urol 61(Suppl 1):S43","journal-title":"Investig Clin Urol"},{"issue":"4\u20135","key":"6187_CR83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.resmic.2019.03.003","volume":"170","author":"JH Shin","year":"2019","unstructured":"Shin JH, Park YH, Sim M, Kim SA, Joung H, Shin DM (2019) Serum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome. Res Microbiol 170(4\u20135):192\u2013201","journal-title":"Res Microbiol"},{"issue":"1","key":"6187_CR84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.juro.2017.08.001","volume":"199","author":"E Shrestha","year":"2018","unstructured":"Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM et al (2018) Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 199(1):161\u2013171","journal-title":"J Urol"},{"issue":"6264","key":"6187_CR85","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science 350(6264):1084\u20131089","journal-title":"Science"},{"issue":"3","key":"6187_CR86","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"6187_CR87","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/nu13072217","volume":"13","author":"M Szczyrek","year":"2021","unstructured":"Szczyrek M, Bitkowska P, Chunowski P, Czuchryta P, Krawczyk P, Milanowski J (2021) Diet, microbiome, and cancer immunotherapy\u2014a comprehensive review. Nutrients 13(7):2217","journal-title":"Nutrients"},{"issue":"12","key":"6187_CR88","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15698\/mic2022.12.787","volume":"9","author":"S Terrisse","year":"2022","unstructured":"Terrisse S, Zitvogel L, Kroemer G (2022) Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy. Microb Cell 9(12):190\u2013194","journal-title":"Microb Cell"},{"issue":"22","key":"6187_CR89","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.1073\/pnas.1321884111","volume":"111","author":"O Twu","year":"2014","unstructured":"Twu O, Dess\u00ed D, Vu A, Mercer F, Stevens GC, De Miguel N et al (2014) Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc Natl Acad Sci USA 111(22):8179\u20138184","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6264","key":"6187_CR90","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079\u20131084","journal-title":"Science"},{"issue":"6161","key":"6187_CR91","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daill\u00e8re R, Hannani D et al (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342(6161):971\u2013976","journal-title":"Science"},{"issue":"1","key":"6187_CR92","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/cancers11010038","volume":"11","author":"S Vivarelli","year":"2019","unstructured":"Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S et al (2019) Gut microbiota and cancer: from pathogenesis to therapy. Cancers 11(1):38","journal-title":"Cancers"},{"issue":"15","key":"6187_CR93","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/pros.24776","volume":"84","author":"C Wakamori","year":"2024","unstructured":"Wakamori C, De Velasco MA, Sakai K, Kura Y, Matsushita M, Fujimoto S et al (2024) A cross-species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk. Prostate 84(15):1375\u20131386","journal-title":"Prostate"},{"key":"6187_CR94","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5114\/aoms.2015.50970","volume":"2","author":"H Yu","year":"2015","unstructured":"Yu H, Meng H, Zhou F, Ni X, Shen S, Das UN (2015) Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia. AOMS 2:385\u2013394","journal-title":"AOMS"},{"issue":"2","key":"6187_CR95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5213\/inj.2015.19.2.74","volume":"19","author":"SJ Yun","year":"2015","unstructured":"Yun SJ, Jeong P, Kang HW, Kim YH, Kim EA, Yan C et al (2015) Urinary MicroRNAs of prostate cancer: virus-encoded hsv1-miRH18 and hsv2-miR-H9-5p could be valuable diagnostic markers. Int Neurourol J 19(2):74\u201384","journal-title":"Int Neurourol J"},{"issue":"1","key":"6187_CR96","doi-asserted-by":"publisher","first-page":"e0147218","DOI":"10.1371\/journal.pone.0147218","volume":"11","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yi M, Zha L, Chen S, Li Z, Li C et al (2016) Sodium butyrate induces endoplasmic reticulum stress and autophagy in colorectal cells: implications for apoptosis. PLoS ONE 11(1):e0147218","journal-title":"PLoS ONE"},{"issue":"1","key":"6187_CR97","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-biodatasci-031121-103035","volume":"4","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Thompson KN, Branck T, Yan Y, Nguyen LH, Franzosa EA et al (2021) Metatranscriptomics for the human microbiome and microbial community functional profiling. Annu Rev Biomed Data Sci 4(1):279\u2013311","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"1","key":"6187_CR98","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00345-024-05403-5","volume":"43","author":"J Zhang","year":"2025","unstructured":"Zhang J, Lou K, Chi J, Wu J, Fan X, Cui Y (2025) Research progress on intratumoral microorganisms in renal cancer. World J Urol 43(1):72","journal-title":"World J Urol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06187-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:46:51Z","timestamp":1757184411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06187-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":98,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["6187"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06187-w","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"178"}}